Cardiol Therapeutics Inc. (CRDL.TO)

CAD 1.96

(0.51%)

Eps Summary of Cardiol Therapeutics Inc.

  • Cardiol Therapeutics Inc.'s latest annual eps in 2023 was -0.44 CAD , down -144.44% from previous year.
  • Cardiol Therapeutics Inc.'s latest quarterly eps in 2024 Q2 was -0.10 CAD , up 31.5% from previous quarter.
  • Cardiol Therapeutics Inc. reported an annual eps of -0.18 CAD in 2022, up 68.42% from previous year.
  • Cardiol Therapeutics Inc. reported an annual eps of -0.57 CAD in 2021, up 17.39% from previous year.
  • Cardiol Therapeutics Inc. reported a quarterly eps of -0.14 CAD for 2024 Q1, down -16.67% from previous quarter.
  • Cardiol Therapeutics Inc. reported a quarterly eps of -0.12 CAD for 2023 Q4, down -30.43% from previous quarter.

Annual Eps Chart of Cardiol Therapeutics Inc. (2023 - 2017)

Historical Annual Eps of Cardiol Therapeutics Inc. (2023 - 2017)

Year Eps Eps Growth
2023 -0.44 CAD -144.44%
2022 -0.18 CAD 68.42%
2021 -0.57 CAD 17.39%
2020 -0.69 CAD -27.78%
2019 -0.54 CAD 47.57%
2018 -1.03 CAD -1309.03%
2017 -0.07 CAD 0.0%

Peer Eps Comparison of Cardiol Therapeutics Inc.

Name Eps Eps Difference
Aurora Cannabis Inc. -1.60 CAD 72.5%
Avicanna Inc. -0.09 CAD -372.61%
Avant Brands Inc. -0.61 CAD 27.869%
Crescita Therapeutics Inc. -0.10 CAD -348.98%
Knight Therapeutics Inc. -0.16 CAD -175.0%
MediPharm Labs Corp. -0.04 CAD -1122.222%
OrganiGram Holdings Inc. -2.82 CAD 84.397%
Canopy Growth Corporation -8.79 CAD 94.994%
Willow Biosciences Inc. -0.10 CAD -340.0%
Auxly Cannabis Group Inc. -0.04 CAD -879.955%